Elrexfio 76 mg (Elranatamab SOLUTION) 76 MG

Elrenatamab 76 mg solution is a subcutaneous medication used for targeted therapy. Learn about its uses, effects, and precautions for informed healthcare decisions.

Strength

76 MG

Manufacturer / TM Owner

PFIZER CANADA ULC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Elrenatamab 76 mg is primarily used in the treatment of certain cancers. This medication works by targeting specific proteins on cancer cells, helping to slow or stop their growth. It is often prescribed for patients who have not responded to other treatments. Elrenatamab 76 mg solution is administered subcutaneously, making it a convenient option for some patients.

Side Effects

Common effects of elrenatamab 76 mg may include injection site reactions, fatigue, and nausea. Some patients may also experience changes in blood cell counts. These effects can vary widely depending on individual health factors and the specific condition being treated. Always consult a healthcare provider for personalized information.

Precautions & Warnings

Elrenatamab 76 mg should be handled with care, following the instructions provided by a healthcare professional. It is important to monitor for any signs of infection or unusual bleeding while using this medication. Patients should also be aware of potential allergic reactions and seek immediate medical attention if severe symptoms occur.

Avoid Interactions

Elrenatamab 76 mg may interact with other medications, including those that affect the immune system. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also affect the efficacy of elrenatamab 76 mg, so it is best to discuss these with a healthcare professional.

Frequently Asked Questions

Elrenatamab 76 mg is used in the treatment of certain cancers, particularly those that have not responded to other treatments.

Elrenatamab 76 mg is administered subcutaneously, which means it is injected under the skin.

Common side effects may include injection site reactions, fatigue, and nausea. Always consult a healthcare provider for detailed information.

Elrenatamab 76 mg may interact with other medications, so it is important to discuss all current medications with a healthcare provider.

If you experience severe side effects, seek immediate medical attention and inform your healthcare provider.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.